✦ LIBER ✦

PCV11 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR THROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT OR TOTAL KNEE REPLACEMENT IN COLOMBIA

✍ Scribed by Pereira, R; Duran, A; Lindner, L; Toro, W; Arango, CH

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV38 COST-EFFECTIVENESS OF RIVAROXABAN

✍ J Kim; R Pollock; S Jung; A Diamantopoulos; M Lees 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

PCV93 THROMBOPROPHYLAXIS AFTER TOTAL KNE

✍ M Lukac; J Bielik; M Lees; D Tomek; V Foltan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCV43 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV49 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PCV19 COST-EFFECTIVENESS OF RIVAROXABAN

✍ Chen, XB; Eggington, S; Wang, CY; Zhu, M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

A multi-perspective cost-effectiveness a

✍ Sonja Zindel, Stephanie Stock, Dirk Müller, Björn Stollenwerk 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 934 KB